Terminology
Methods
Findings
100

What is an RBD?

The Receptor Binding Domain on the coronavirus spike protein, where the virus attaches to ACE2 receptors on host cells

100

What was the main hypothesis tested in this study?

Mosaic RBD nanoparticles induce broader and stronger immune responses than homotypic SARS-2 vaccines.

100

Which vaccine group showed the highest survival rate after SARS-1 challenge?

Mosaic-8b vaccinated mice

200

What does homotypic mean?

A nanoparticle displaying RBDs from only one virus strain (e.g., SARS-2 Beta)

200

How was the SpyTag-SpyCatcher system used to build mosaic nanoparticles?

The SpyTag-SpyCatcher system covalently attached RBDs to a 60-mer mi3 protein scaffold to form the mosaic nanoparticle

200

Which group of mice showed the least weight loss, indicating stronger protection?

The mosaic vaccinated mice (Mosaic-8b and Mosaic-8gm groups)

300

What is a sarbecovirus?

A subgroup of betacoronaviruses that includes SARS-CoV-1, SARS-CoV-2, and related bat viruses

300

What test measured how strongly antibodies bind to RBDs?

Elisa (enzyme-linked immunosorbent assay)

300

In non-human primates, how many immunizations were given before viral challenge?

Monkeys received three doses (prime + two boosts) before being challenged

400

What is a nanoparticle vaccine?

A vaccine platform that uses a protein scaffold to present viral antigens in a repetitive, ordered structure to the immune system

400

What method tested virus blocking ability?

Pseudovirus neutralization assay

400

What did Figures 4B/C show about antibody breadth against SARS-2 and other sarbecoviruses?

Mosaic-8b induced high antibody titers and strong neutralization across both SARS-2 variants and distant sarbecoviruses.

500

What are mosaic nanoparticles, and why are they important?

Nanoparticles displaying RBDs from multiple sarbecoviruses; they trigger broad cross-reactive immunity and may protect against future coronavirus spillovers

500

What makes the Authentic Virus Neutralization test different from ELISA or pseudovirus assays?

It uses live virus instead of viral proteins or pseudoviruses, showing real-world antibody protection.

500

What was the overall conclusion of the paper?

Mosaic RBD nanoparticles elicit broad, cross-protective antibody responses across diverse sarbecoviruses in animal models, supporting their potential as universal coronavirus vaccines